Autism typically presents with a highly heterogeneous set of features, including frequent 22
comorbidity with intellectual disability (ID) . The overlap between these two phenotypes has 23 confounded the accurate diagnosis and discovery of genetic factors associated with autism. We 24 analyzed genetic variants in 2,290 individuals with autism from the Simons Simplex Collection 25 (SSC) who have either ID or normal cognitive function to determine whether genes associated 26 with autism also contribute towards ID comorbidity. We found that individuals who carried 27 variants in a set of 173 reported autism-associated genes showed decreased IQ (p=5.49×10 -6 ) and 28 increased autism severity (p=0.013) compared with individuals without such variants. A subset 29 of autism-associated genes also showed strong evidence for ID comorbidity in published case 30 reports. We also found that individuals with high-functioning autism (IQ>100) had lower 31 frequencies of CNVs (p=0.065) and LGD variants (p=0.021) compared with individuals who 32 manifested both autism and ID (IQ<70). These data indicated that de novo LGD variants 33 conferred a 1.53-fold higher risk (p=0.035) towards comorbid ID, while LGD mutations 34 specifically disrupting autism-associated genes conferred a 4.85-fold increased risk (p=0.011) for 35 comorbid ID. Furthermore, de novo LGD variants in individuals with high-functioning autism 36 were more likely to disrupt genes with little functional relevance towards neurodevelopment, as 37 demonstrated by evidence from pathogenicity metrics, expression patterns in the developing 38 brain, and mouse model phenotypes. Overall, our data suggest that de novo pathogenic variants 39 disrupting genes associated with autism contribute towards autism and ID comorbidity, while 40 other genetic factors are likely to be causal for high-functioning autism. 41 repetitive behavior, and restricted interests 1 , is a highly heterogeneous neurodevelopmental 44 disorder characterized by complex genetic etiology and strong comorbidity with other 45 developmental disorders 2 . For example, approximately 30% of individuals with autism also 46 manifest with intellectual disability (ID) 3 , defined 1 by IQ scores <70. The high degree of co-47 occurrence of autism with ID has been shown to confound accurate diagnosis of autism. In fact, 48
we recently showed that 69% of individuals diagnosed with ID are likely to be recategorized and 49 diagnosed with autism 4 . The diagnostic overlap between autism and ID suggests that de novo 50 gene disruptive variants and copy-number variants (CNVs) identified in individuals ascertained 51 for autism in large-scale studies could also be confounded by ID comorbidity. Here, using 52 genetic and phenotypic data from 2,290 individuals with autism from the Simons Simplex 53 Collection (SSC) 5 , we show that gene discoveries in autism are biased towards genes that 54 contribute towards both autism and comorbid ID. 55
We analyzed rare de novo likely-gene disruptive (LGD) variants from exome sequencing 56 data 6,7 , disease-associated copy-number variants (CNVs) from microarrays 8 , and Full-scale IQ 57
and Social Responsiveness Scale (SRS) T-scores for SSC probands that were obtained from the 58 Simons Foundation Autism Research Initiative 5 . As these data were de-identified, they were 59 exempt from IRB review and conformed to the Helsinki Declaration. We first compared the 60 phenotypes of 288 individuals with de novo LGD variants and 81 individuals with pathogenic 61
CNVs to 1,921 individuals without such variants obtained from the SSC cohort. Similar to 62 previous autism studies that identified correlations between de novo variants and IQ scores 9-12 , 63 sequencing studies (Table S1 ). These genes included tier 1 genes (>2 de novo LGD variants) 74 from the Developing Brain Disorders Gene Database 13 , genes with >5 non-SSC de novo LGD 75 variants from denovo-db 14 , and SFARI Gene tiers 1 and 2 (https://gene.sfari.org/). We found that 76 individuals carrying de novo LGD variants in autism-associated genes had decreased IQ (n=74, 77 IQ=69.1, p=5.49×10 -6 , two-tailed Mann-Whitney test) and increased SRS T-scores (SRS=82.4, 78 p=0.013) compared with individuals without LGD variants (n=2,216, IQ=81.9, SRS=79.6), 79
implying that candidate autism genes contribute to both autism and ID phenotypes ( Figure 1B) . 80
To validate this finding, we examined 76 published case reports of affected individuals with 81 pathogenic variants in a subset of 22 autism genes that appeared in all three autism gene 82 databases ( Table 1 , Table S2 ). For example, recent case studies have identified autism co-83 occurring with ID in 21 individuals with de novo SHANK3 variants 15 , 19 individuals with 84 NRXN1 variants 16 , and 18 individuals with TCF20 variants 17 . Overall, 460/497 (92.6%) 85 individuals with autism described in these studies had ID features, emphasizing that variants in 86 these genes contribute to a severe form of autism with comorbid ID (Table 1) . 87
We next compared genetic data from 397 SSC individuals (17.3% of the SSC cohort) 88
with "high-functioning autism", defined as having severe autism and average or above-average 89 IQ scores (SRS>75 and IQ>100), to 562 individuals (24.5%) with both autism and ID (SRS>75 90 and IQ<70). Individuals with high-functioning autism had a significantly lower (p=0.021, one-91 tailed Fisher's Exact test) frequency of de novo LGD variants (42/397, 10.6%) than individuals 92 with autism and ID (86/562, 15.3%). Similarly, individuals with high-functioning autism were 93 less likely (p=0.065) to carry pathogenic CNVs (9/397, 2.3%) than individuals with autism and 94 5 in autism-associated genes, including ANK2, HIVEP3, and BAZ2B. This frequency was not 105 significantly different from the expected frequency of de novo variants in the general population 106 (p=0.095, one-tailed Student's T-test), as calculated from gene-specific probabilities of de novo 107 nonsense and frameshift variants from a sequence context-dependent model 9 . In contrast, 20/562 108 (3.6%) individuals with autism comorbid with ID carried de novo LGD variants in autism-109 associated genes, such as CHD8, SCN2A, and SYNGAP1, representing a 19.2-fold enrichment of 110 variants compared with the expected rate in the general population (p=9.48×10 -6 ). Thus, de novo 111
LGD variants in autism genes conferred a 4.85-fold increased risk (p=0.011, 95% CI 1.43-16.42) 112 towards comorbid ID in individuals with autism. 113
We further sought to determine the biological relevance of the 42 genes with de novo 114
LGD variants identified in individuals with high-functioning autism, and found that these genes 115 in aggregate had less functional relevance towards neurodevelopment than the reported autism-116 associated genes. For example, genes with de novo LGD variants in individuals with high-117
functioning autism were less resistant to genetic variation than reported autism-associated genes, 118
as measured by Residual Variation Intolerance Score (RVIS) (p=4.00×10 -4 , Mann-Whitney two-119 tailed test) and pLI percentile (p=9.77×10 -7 ) gene metrics 19, 20 (Figure 2A) . In fact, while the 120 RVIS and pLI percentiles of the reported autism genes were clustered below the thresholds for 121 pathogenicity (RVIS <20 th percentile and pLI <18 th percentile, or raw score >0.9), genes 122 disrupted among individuals with high-functioning autism were evenly distributed across the 123 range of percentiles. Additionally, we tested the enrichment of each gene set for specific 124 expression in brain regions during development, based on expression data derived from the 125 6 variants in individuals with high-functioning autism are less pathogenic in humans and model 136 organisms, and therefore may not necessarily contribute towards the specific high-functioning 137 autism phenotype. 138
Our data indicate that pathogenic variants such as de novo LGD variants and CNVs 139 contribute to autism phenotypes primarily in individuals with comorbid ID, especially if the 140 variants disrupt a gene previously associated with autism. Several themes regarding the study of 141 high-functioning autism have emerged from these findings. First, the consistently high degree of 142 comorbidity between autism and ID has led to an ascertainment bias towards individuals who 143 manifest both disorders in large-scale sequencing cohorts, as it is difficult to exclude all 144 individuals with comorbid disorders and still have adequate power to identify recurrent variants. 145
Indeed, more than 80% of the SSC cohort had an IQ score less than 100, and the average IQ of 146 the cohort (81.5) was 18.5 points below the population average. This bias has contributed to the 147 identification of genes and CNV regions related to both autism and ID, as evidenced by the 148 decreased IQ among carriers of variants in these genes as well as a high incidence of comorbid 149 phenotypes reported in published case studies. Large-scale sequencing studies still hold a high 150 value in uncovering shared biological mechanisms that could underlie both disorders 23 . 151
However, understanding the biology of the core autism phenotypes would require concerted 152 efforts to recruit individuals who specifically manifest high-functioning autism without ID. 153
Second, individuals with high-functioning autism are less likely to carry de novo LGD 154 variants in candidate autism genes, and de novo variants in individuals with high-functioning 155 autism tend to disrupt genes with less functional relevance towards neurodevelopment. These 156 genes likely carry non-recurrent variants that either confer a small effect size towards autism risk 157 on their own, or are not associated at all with neurodevelopment. We therefore propose that 158 multiple genomic factors with varying effect sizes, such as missense variants, common variants, 159 variants in regulatory and non-coding regions, or the combinatorial effects of inherited variants, 160 contribute towards autism phenotypes without ID. For example, Schaaf and colleagues 161 performed targeted sequencing of 21 candidate autism genes in 339 individuals with high-162
functioning autism 25 . They found that 2% of individuals carried de novo missense variants in 163 candidate autism genes, such as PTEN and FOXP2, suggesting that allelic variants of differing 164 severity within the same gene might contribute to distinct neurodevelopmental trajectories. 7 carried multiple inherited missense variants in candidate autism genes, potentially contributing to 167 an oligogenic model for high-functioning autism phenotypes. Similarly, common variants have 168 been found to contribute towards increased autism risk in individuals without ID 26, 27 . For 169 example, Grove and colleagues recently reported that the heritability attributed to common 170 variants, including those primarily associated with cognitive ability and educational attainment, 171 was three times lower in individuals with autism and ID compared with those without ID 27 . 172
Finally, variants that may not contribute directly towards autism phenotypes themselves, 173
including the de novo LGD variants observed in individuals with high-functioning autism, could 174 still be responsible for subtler modification of the severity of autism or ID phenotypes. 175
Overall, our results emphasize the importance of dissecting phenotypic heterogeneity in 176 family-based sequencing studies of complex diseases, especially those with a high frequency of 177 comorbid disorders. While a larger cohort of individuals recruited specifically for high-178
functioning autism could identify associations with recurrent genes or different types of variants, 179 these findings should be validated using functional studies to more fully differentiate the genetic 180 causes for high-functioning autism from those for autism with comorbid ID. 181
Supplemental data include two supplemental tables in Excel file format. 184 185
Declaration of Interests 186
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